While the strong biotin-avidin interaction has been widely used for the detection of biomolecules, its irreversibility complicates their isolation. We report the synthesis of a photocleavable biotin derivative (PCB) which eliminates many limitations of existing methods. This reagent contains a biotin moiety linked through a spacer arm to a photocleavable moiety, which reacts selectively with primary amino groups on any substrate. In experiments using [leucine] -enkephalin as a model substrate, we show that PCB retains its high affinity toward avidin/streptavidin and allows rapid (<5 min) and efficient (>99%o) photorelease of the substrate in a completely unaltered form. Photocleavable biotins should be useful in numerous applications involving the isolation of proteins, nucleic acids, lipids, and cells.
The use of avidin-biotin technology has become increasingly important in numerous areas of biochemistry, molecular biology, and medicine (1-3), including detection of proteins by nonradioactive immunoassays (4), cytochemical staining (5), cell separation (6) , and isolation of nucleic acids and detection of specific DNA/RNA sequences by hybridization (7) . The technique derives its usefulness from the extremely high affinity of the avidin-biotin interaction (association constant 1015 M-1) and the ability to biotinylate a wide range of target biomolecules such as antibodies, nucleic acids, and lipids.
The first step in the isolation of a target molecule is its biotinylation or the biotinylation of a biomolecule which ultimately binds to the target molecule (e.g., an antibody or hybridization probe that forms a target complex). The biotinylated molecule or the target complex is then separated from other molecules in a heterogeneous mixture by using affinity media based on the avidin-biotin interaction (1) . Once the target molecule is bound through the avidin-biotin interaction, it is often important to recover it in an unmodified and biologically functional form. Existing methods for release of the target include (i) dissociation of the biotin-avidin complex (6-8 M guanidinium chloride) (3); (ii) utilization of biotin analogs with decreased affinity towards avidin (e.g., iminobiotin) (8) ; and (iii) use of biotinylation reagents with cleavable spacer arms [e.g., S-S-biotin (9) ]. However, none of these methods allows release of the target molecule or the target complex in an unaltered form, since the biotin or part of the cleavable spacer arm remains attached. In addition, these procedures involve conditions which often denature the target biomolecule.
In this study we report synthesis, characterization, and application of a photocleavable biotin derivative (PCB), which eliminates many limitations of existing methods. This reagent, termed PCB-NHS ester, contains a biotin moiety linked through a spacer arm to a photocleavable 1-(2-nitrophenyl)-ethyl moiety derivatized with N-hydroxysuccinimidyl mixed carbonate, which reacts selectively with primary amino groups on the target molecule to form a stable carbamate. The PCB-target biomolecule conjugate undergoes an efficient photoreaction upon 300-nm illumination, resulting in the rapid and complete release of the target molecule in an unmodified form.
MATERIALS AND METHODS
All chemicals were purchased from Aldrich unless otherwise indicated. 1H NMR spectra were recorded on a Varian XL-400 spectrometer at 400 MHz in perdeuterated dimethyl sulfoxide solution. Emission spectra were measured on an SLM 48000 fluorimeter using 380-nm excitation. IR spectra were recorded on a Nicolet 740 Fourier transform IR spectrometer.
Synthesis of PCB-NHS Ester. Synthesis of PCB-NHS ester was accomplished as shown in Scheme I. 
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washed with chlorobenzene (10 ml) and diethyl ether (20 ml). The intermediate 2 (2.93 g; 7.36 mmol) was suspended in 35 ml of 95% (vol/vol) ethanol and then concentrated HCI (3.12 ml; 5 eq) was added. The mixture was stirred overnight and then evaporated to dryness. Dimethylformamide (10 ml) was added to the residue, containing 5-aminomethyl-2-nitroacetophenone hydrochloride (3) and ammonium chloride (which remains as a precipitate), followed by 6-biotinamidocaproic acid (3.29 g; 1.25 eq, in 35 ml of N-methylpyrrolidone), dicyclohexyl carbodiimide (DCC; 2.28 g; 1.5 eq), and triethylamine (1.28 ml;
1.25 eq). The solution was stirred overnight at room temperature, the precipitate was filtered off, and the filtrate was added to 700 ml of diethyl ether. The resulting precipitate was dried and purified on a silica gel column using a step gradient [5-20% (vol/vol) MeOH in CHCl3] to give 5-(6-biotinamidocaproamidomethyl)-2-nitroacetophenone (4) (2.27 g, 58% yield).
Intermediate 4 (1 g; 1.87 mmol) was dissolved in 15 ml of 70% (vol/vol) EtOH, and after the solution had been cooled to 0°C, sodium borohydride (141 mg; 4 eq) was added. The solution was stirred at 0°C for 30 min and at room temperature for an additional 2 hr. The reaction was quenched by addition of 1 ml of acetone, and the mixture was neutralized with 0.1 M HCl and concentrated to about 5 ml. The aqueous layer was decanted and the residue was washed with water (three times, 5 ml each) and dried to give 5-(6-biotinamidocaproamido-
Compound 5 was converted into PCB-NHS ester 6 by using a modification of a procedure described previously (13) . Compound 5 (1.07 g; 2 mmol) was dissolved in 10 ml of dimethylformamide. To this solution N,N'-disuccinimidyl carbonate (Fluka) (1 g; 1.5 eq) was added, followed by triethylamine (0.81 ml; 3 eq). After stirring at room temperature for 5 hr, solvents were evaporated to dryness. The residue was washed consecutively with 0.1 M NaHCO3, water, dioxane, and diethyl ether, and then dried to give (10 ,ul, 10 mg/ml in dry acetone) was added to a solution of [Leu]Enk (10-125 nmol) in sodium borate buffer (pH = 9.0; final volume = 3 ml), and the solution was incubated for 10 min. Fluorescence was measured at 488 nm after excitation at 383 nm. The assay was found to be linear in the concentration range studied.
The time dependence for photocleavage of PCB-[Leu]Enk was studied by removing small aliquots from the photoreaction at various times of irradiation, and the concentration of released
[Leu]Enk was determined by the fluorescamine assay.
RESULTS
The synthesized PCB 6 referred to here as PCB-NHS ester (see Scheme I) consists of a biotinyl moiety linked through a spacer arm (6-aminocaproic acid) to an a-substituted 2-nitrobenzyl nucleus bearing an N-hydroxysuccinimidyl reactive group (NHS carbonate). The spacer was introduced to allow for effective binding to streptavidin. The a-substituted 2-nitrobenzyl moiety was selected because its derivatives, such as esters and amides, are known to exhibit highly efficient and fast photoreactions (14, 15) . NHS esters and carbonates react selectively under mild conditions (pH = 8) with primary amino groups to give amides and carbamates, respectively (1, 13).
The properties of the PCB-NHS ester 6 were studied with
[Leu]Enk, a pentapeptide (Tyr-Gly-Gly-Phe-Leu), as a model substrate (Scheme II). (Fig. 1 Inset) . These two peaks can be attributed to PCB-[Leu]Enk, with the separation most likely due to its two diastereoisomeric forms (16) . 
DISCUSSION
In this work we have designed and synthesized a PCB that can be used as a reagent to label biomolecules. There are several properties that are important for a PCB to be useful in the isolation of biomolecules. They include the following:
(i) Reactivity. The PCB should react selectively and efficiently with a wide range of target molecules under mild conditions.
(ii) Complexation. The PCB should retain biotin's high affinity toward (strept)avidin.
(iii) Photocleavage. The intensity and exposure time of light required for complete photocleavage should be minimal.
(iv) Substrate release. Photocleavage should result in the release of the substrate in an unaltered form.
The PCB-NHS ester reported here satisfies all of these criteria. It reacts with any substrate having a primary amino group under mild conditions, exhibits a high affinity towards (strept)avidin, and allows fast (-4 min) and efficient (-99%) photorelease of the substrate in a completely unaltered form. In addition, biotin-NHS ester and its analogs have been widely used as biotinylation reagents for a variety of biomolecules, including antibodies (3), hormones (1), amino-derivatized nucleic acids (7), and lipids (18) . Similar protocols should be applicable for the biotinylation of these biomolecules with the PCB-NHS ester, thereby expanding the range of applications for biotin-avidin technology.
Importantly, the synthetic strategy employed here for the synthesis of PCB-NHS ester can also be readily adapted for the synthesis of other PCB compounds. For example, by using the current synthetic approach the specific photoreactive moiety, reactive group, and spacer arm can be replaced easily to create a variety of different PCB reagents. Recently, a different approach was reported (19) that did not satisfy requirements i, iii, and iv listed above. In this case, a peptide hormone (cholecystokinin) was synthesized containing biotin linked via a 2-nitrobenzyl ester moiety. Thus, this approach did not involve synthesis of a PCB reagent (property i). In addition, photocleavage required a long time (40 min) at a high intensity of UV light (200-W mercury arc lamp) (property iii) and resulted in only 46% recovery of a modified peptide hormone having the spacer arm and 2-nitrosobenzaldehyde moiety still covalently attached (property iv).
In general, photocleavable biotin reagents such as PCB-NHS ester overcome one of the most critical limitations of avidin-biotin technology-i.e., the irreversibility of the avidinbiotin interaction-without sacrificing the high affinity of this interaction. PCBs are expected to be useful in a variety of applications relating to the isolation of biological molecules. Suitable target biomolecules include proteins, nucleic acids, carbohydrates, lipids, and macromolecular assemblies. PCB should also be useful in the isolation of cells expressing unique cellsurface antigen which are targets of PCB-labeled antibodies. In addition to reacting directly with biomolecules, PCBs can also be incorporated during their synthesis. For example, PCBs can be introduced into nascent proteins during in vitro synthesis by using suitable aminoacyl-tRNAs, such as lysyl-tRNA, that will selectively react with PCB-NHS ester. This will be especially useful for the isolation of nascent proteins modified by site-directed isotope labeling (20) or site-specific nonnative amino acid replacement (21, 22) .
